Meeting Registration|Hotel Registration|Platform Presentation | Presentation Guidelines  

Alcalde XXIII

April 16-17, 2009

CALL FOR ABSTRACTS

PLATFORM PRESENTATIONS

Alcalde XXIII, the Twenty-third Annual Southwest Leadership Conference, intends to provide encouragement and learning experiences which will promote creativity, Scholarship and leadership and will promote the presentation of evidence based research at national meetings. To the extent possible, the process adopted for presentation at Alcalde is patterned after that of ASHP, so as to provide a practical experience in getting ready for a national presentation. All residents and fellows are strongly encouraged to submit abstracts of papers to be presented at SWLC for pharmacy residents, fellows, and preceptors.

The presentation format includes 15 minutes of lecture and five minutes of questions-and-answers. The presentation must be in a Power Point format; an LCD Projector and screen will be provided. Abstracts should be submitted no later than February 28, 2009 via e-mail.  Residents and fellows must submit their presentation in PowerPoint format no later than Saturday, March 21, 2009.  Changes to presentations will not be allowed after this time.  Please submit the PowerPoint presentation with a title using your name; E.g. JaneResident.ppt to Linda Albrecht at lalbrech@yahoo.com.

Papers are sought in the following categories for platform presentation:

CLINICAL RESEARCH

This category includes reports of well-conducted original research on drug effects in humans. Examples of topics that might be covered include the following:

· comparative efficacy and safety evaluations of two or more drug therapies;

· exploratory studies on the clinical pharmacology and pharmacokinetics of  investigational  drugs;

· analyses of the incidence and severity of adverse drug reactions;

· bioavailability studies in human subjects; and

· comparative evaluations of the clinical usefulness of various laboratory methods.

COMMAND PERFORMANCE REPORTS

This category includes clinical research reports that have been presented elsewhere. Submissions must be reports of original research in clinical or laboratory research.

EVALUATIVE STUDIES

These submissions must report completed original research. Included in this category are evaluative studies of new roles or services in institutional pharmacy practice.

DESCRIPTIVE REPORTS

These are contributions reporting new, improved, or innovative roles or services in pharmacy practice that have not been evaluated formally, but are of such importance that they should be brought to the attention of other practitioners. Also, reports of clinical cases that do not meet the criteria for evaluative studies fall into this category. Examples of the latter include reports of unusual drug reactions involving only one or a few patients or unique uses of drugs in a limited number of patients when the drugs involved are important therapeutic agents.

RESEARCH-IN-PROGRESS

These reports present uncompleted evaluative studies (or clinical/laboratory research) that are currently in progress and will most likely still be in progress at the time of the meeting. Research-in-progress reports allow investigators to bring their projects to the attention of colleagues earlier than would otherwise be possible. In addition, a forum is provided for investigators to benefit from peer review at a stage when appropriate modifications can still be made in study methods, data collection and analysis or interpretation of results.

CASE STUDIES IN HOSPITAL PHARMACY MANAGEMENT

These management case studies are intended to take the audience through an analysis of the sequential steps or processes involved in resolving a particular problem, implementing a change, developing and implementing a new system or program, planning and organizing an administrative function, or some other example of applied institutional pharmacy management. The primary objective is not simply to offer a forum for the presenter to tell the audience what was done, but rather to join the audience in a critical analysis of the case.

LABORATORY RESEARCH

One component of each of the specialty residency standards for accreditation by ASHP is an investigational or research project. There are also a number of Clinical Sciences Fellowship programs in the Southwest, and these are especially oriented toward research. In some cases laboratory research is conducted, and the SWLC would encourage persons engaged in this type of scholarly work to present reports on completed projects or in the category, "Research-in-Progress." (ASHP does not include "Laboratory Research" as one of its categories.) 

SELECTED PRESENTATIONS (Examples) – Alcalde XIX

Psychiatric Practice

Menantine in the Treatment of Attention Deficit and Hyperactivity Disorder in Children

Evaluation of an Inpatient Psychopharmacology Consult Service

PAIN MANAGEMENT

Impact of Safety Initiatives on the Usage of Fentanyl Transdermal Patches

Naloxone Utilization in Determining Appropriate Opioid Use, Avoiding Effects, and Minimizing Medication Errors

CARDIOVASCULAR MEDICINE

Percutaneous Coronary Interventions in Patients with Chronic Stable Angina:  Quality of Care in an Academic VA Medical Center

Dobutamine Versus Milrinone in Trauma Resuscitation:  A Retrospective Analysis

HEMATOLOGY/ONCOLOGY

Evaluation of a Cetuximab-Based Regimen Compared to Standard Therapies for Metastatic Colorectal Cancer

Economic Analysis of Bevacizumab (Avastin™) in Combination with Standard Chemotherapy for Advanced or Metatstatic Colorectal Cancer

ANTICOAGULATION THERAPY

Evaluation of Clinical and Economic Outcomes of a Pharmacist-Managed Anticoagulation Service Versus that of Usual Care: A Retrospective Observational Study

Utilization of Argatroban and Lepirudin in Patients with a Clinical Suspicion of Heparin Induced Thrombocytopenia or Diagnosed Heparin Induced Thrombocytopenia

INFECIOUS DISEASE

Comparison of the In Vitro Activity of Tigecycline, Minocycline, and Tetracycline Against Gram Negative Bacteria

Antibacterial Activity of Colistin and Polymyxin B Against Multidrug Resistant Pseudomonas Aeruginosa, Alcaligenes Species, and Stenotrophomonas Maltophilia

DIABETES MANAGEMENT

Evaluation of Glycemic Control with Continuous Infusion and Sliding Scale Insulin Regimens in Medical Intensive Care Unit (MICU) Patients

Identification of Barriers to Appropriate Dietary Behavior and Evaluation of their Relative Importance in Oklahoma Medicaid Patients with Type 2 Diabetes Mellitus

AMBULATORY CARE

Evaluating the Use and Misuse of Non-Steroidal Anti-Inflammatory Drugs in a Community Pharmacy Setting

Salmeterol as Monotherapy and in Combination with Inhaled Corticosteroids: A Retrospective Evaluation of Utilization and Asthma Patient Outcomes

LIPID MANAGEMENT

Concurrent Use of High Dose Simvastatin and Gemfibrozil in Patients with Dyslipidemia

Evaluation of HMG-CoA Utilization and Patient Therapeutic Goals with Pharmacoeconomic Impact

CLINICAL PRACTICE

Comparison of Low-Dose Granisetron Hydrochloride (KytrilŇ) Versus Ondansetron Hydrochloride (ZofranŇ) in Adult Patients as Prophylaxis of Postoperative Nausea and Vomiting

Practice Pattern Changes in Antithrombotic Prophylaxis and Thromboembolic Events Following Hip and Knee Replacement at a Tertiary Hospital